Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Genetic mannose binding lectin deficiency is associated with airway microbiota diversity and reduced exacerbation frequency in COPD.

Dicker AJ, Crichton ML, Cassidy AJ, Brady G, Hapca A, Tavendale R, Einarsson GG, Furrie E, Elborn JS, Schembri S, Marshall SE, Palmer CNA, Chalmers JD.

Thorax. 2018 Jun;73(6):510-518. doi: 10.1136/thoraxjnl-2016-209931. Epub 2017 Nov 3.

2.

A molecular approach towards taxonomic identification of elasmobranch species from Maltese fisheries landings.

Vella A, Vella N, Schembri S.

Mar Genomics. 2017 Dec;36:17-23. doi: 10.1016/j.margen.2017.08.008. Epub 2017 Oct 3.

PMID:
28923557
3.

Oral versus intravenous clarithromycin in moderate to severe community-acquired pneumonia: an observational study.

Rae N, Singanayagam A, Schembri S, Chalmers JD.

Pneumonia (Nathan). 2017 Feb 5;9:2. doi: 10.1186/s41479-017-0025-2. eCollection 2017.

4.

Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease.

Dicker AJ, Crichton ML, Pumphrey EG, Cassidy AJ, Suarez-Cuartin G, Sibila O, Furrie E, Fong CJ, Ibrahim W, Brady G, Einarsson GG, Elborn JS, Schembri S, Marshall SE, Palmer CNA, Chalmers JD.

J Allergy Clin Immunol. 2018 Jan;141(1):117-127. doi: 10.1016/j.jaci.2017.04.022. Epub 2017 May 13.

5.

Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial.

Sullivan FM, Farmer E, Mair FS, Treweek S, Kendrick D, Jackson C, Robertson C, Briggs A, McCowan C, Bedford L, Young B, Vedhara K, Gallant S, Littleford R, Robertson J, Sewell H, Dorward A, Sarvesvaran J, Schembri S.

BMC Cancer. 2017 Mar 11;17(1):187. doi: 10.1186/s12885-017-3175-y.

6.

Inhaled Corticosteroids for Chronic Obstructive Pulmonary Disease--The Shifting Treatment Paradigm.

Wilkie M, Finch S, Schembri S.

COPD. 2015;12(5):582-90. doi: 10.3109/15412555.2014.995288. Epub 2015 Mar 16. Review.

7.

Quantifying the real life risk profile of inhaled corticosteroids in COPD by record linkage analysis.

Flynn RW, MacDonald TM, Hapca A, MacKenzie IS, Schembri S.

Respir Res. 2014 Nov 19;15:141. doi: 10.1186/s12931-014-0141-y.

8.

Experiencing health care service quality: through patients' eyes.

Schembri S.

Aust Health Rev. 2015 Feb;39(1):109-116. doi: 10.1071/AH14079.

PMID:
25319046
9.

Desmopressin responsiveness at a capped dose of 15  μg in type 1 von Willebrand disease and mild hemophilia A.

Siew DA, Mangel J, Laudenbach L, Schembri S, Minuk L.

Blood Coagul Fibrinolysis. 2014 Dec;25(8):820-3. doi: 10.1097/MBC.0000000000000158.

PMID:
24911459
10.

Thrombocytosis is associated with increased short and long term mortality after exacerbation of chronic obstructive pulmonary disease: a role for antiplatelet therapy?

Harrison MT, Short P, Williamson PA, Singanayagam A, Chalmers JD, Schembri S.

Thorax. 2014 Jul;69(7):609-15. doi: 10.1136/thoraxjnl-2013-203996. Epub 2014 Apr 17.

PMID:
24743560
11.

Simplification of the IDSA/ATS criteria for severe CAP using meta-analysis and observational data.

Salih W, Schembri S, Chalmers JD.

Eur Respir J. 2014 Mar;43(3):842-51. doi: 10.1183/09031936.00089513. Epub 2013 Oct 10. Review.

12.

A multidisciplinary intervention to reduce antibiotic duration in lower respiratory tract infections.

Murray C, Shaw A, Lloyd M, Smith RP, Fardon TC, Schembri S, Chalmers JD.

J Antimicrob Chemother. 2014 Feb;69(2):515-8. doi: 10.1093/jac/dkt362. Epub 2013 Sep 10.

PMID:
24022067
13.

Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease.

Singanayagam A, Schembri S, Chalmers JD.

Ann Am Thorac Soc. 2013 Apr;10(2):81-9. doi: 10.1513/AnnalsATS.201208-043OC. Review.

PMID:
23607835
14.

Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies.

Schembri S, Williamson PA, Short PM, Singanayagam A, Akram A, Taylor J, Singanayagam A, Hill AT, Chalmers JD.

BMJ. 2013 Mar 20;346:f1235. doi: 10.1136/bmj.f1235.

15.

Effect of statins on total cholesterol concentrations, cardiovascular morbidity, and all-cause mortality in chronic obstructive pulmonary disease: a population-based cohort study.

Sheng X, Murphy MJ, MacDonald TM, Schembri S, Simpson W, Winter J, Winter JH, Wei L.

Clin Ther. 2012 Feb;34(2):374-84. doi: 10.1016/j.clinthera.2011.12.014. Epub 2012 Jan 12.

PMID:
22244052
16.

The impact of tiotropium on mortality and exacerbations when added to inhaled corticosteroids and long-acting β-agonist therapy in COPD.

Short PM, Williamson PA, Elder DHJ, Lipworth SIW, Schembri S, Lipworth BJ.

Chest. 2012 Jan;141(1):81-86. doi: 10.1378/chest.11-0038. Epub 2011 Jul 28.

PMID:
21799028
17.

Tiotropium versus salmeterol in COPD.

Schembri S.

N Engl J Med. 2011 Jun 30;364(26):2553; author reply 2553-4. doi: 10.1056/NEJMc1104617. No abstract available.

PMID:
21714655
18.

Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study.

Short PM, Lipworth SI, Elder DH, Schembri S, Lipworth BJ.

BMJ. 2011 May 10;342:d2549. doi: 10.1136/bmj.d2549.

19.

Effects of chlorine and exercise on the unified airway in adolescent elite Scottish swimmers.

Clearie KL, Vaidyanathan S, Williamson PA, Goudie A, Short P, Schembri S, Lipworth BJ.

Allergy. 2010 Feb;65(2):269-73. doi: 10.1111/j.1398-9995.2009.02173.x. Epub 2009 Sep 30.

PMID:
19793061
20.

Asthma in pregnancy.

Schembri S.

N Engl J Med. 2009 Jul 30;361(5):535; author reply 535-6. doi: 10.1056/NEJMc091118. No abstract available.

21.

A predictive model of hospitalisation and death from chronic obstructive pulmonary disease.

Schembri S, Anderson W, Morant S, Winter J, Thompson P, Pettitt D, MacDonald TM, Winter JH.

Respir Med. 2009 Oct;103(10):1461-7. doi: 10.1016/j.rmed.2009.04.021. Epub 2009 Jun 9.

22.

Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD.

Schembri S, Morant S, Winter JH, MacDonald TM.

Thorax. 2009 Jul;64(7):567-72. doi: 10.1136/thx.2008.106286. Epub 2009 Mar 24.

PMID:
19321465
23.

Respiratory symptoms, pulmonary function, and markers of inflammation among bar workers before and after a legislative ban on smoking in public places.

Menzies D, Nair A, Williamson PA, Schembri S, Al-Khairalla MZ, Barnes M, Fardon TC, McFarlane L, Magee GJ, Lipworth BJ.

JAMA. 2006 Oct 11;296(14):1742-8.

PMID:
17032987
24.

[Alcoholic hepatopathy, deficiency pathology and serum transaminases. Presentation of 2 clinical cases].

Borghi E, Melocchi F, Schembri S, Giomi N, Cantini R, Vecce R, Maurini V, Carnicelli A.

Recenti Prog Med. 1991 Jun;82(6):331-3. Italian.

PMID:
1924989
25.

[Increase of liver enzymes during treatment of myocardial infarct using intravenous nitro-derivatives].

Borghi E, Rossini D, Giomi N, Roventini L, Vecce R, Fontanive P, Schembri S, Maurini V, Carnicelli A.

Recenti Prog Med. 1990 Apr;81(4):249-51. Italian.

PMID:
2116031
26.

[A case of wet beriberi].

Borghi E, Maurini V, Roventini L, Schembri S, Vecce R, Giomi N, Cantini R, Rindi M, Carnicelli A.

Recenti Prog Med. 1989 Nov;80(11):588-90. Italian.

PMID:
2623323
27.

[Prolonged use of intravenous nitro derivatives in acute myocardial infarction (AMI)].

Borghi E, Roventini L, Vecce R, Schembri S, Maurini V, Giomi N, Cantini R, Rindi M, Lenzi R, Barzi F, et al.

Minerva Cardioangiol. 1989 Jun;37(6):307-9. Italian.

PMID:
2812448

Supplemental Content

Loading ...
Support Center